The impact of age, performance status and comorbidities on nab-paclitaxel plus gemcitabine effectiveness in patients with metastatic pancreatic cancer

Few studies have evaluated the impact of risk factors such as performance status (PS) and comorbidities on overall survival (OS) in patients with metastatic pancreatic cancer (mPC). We investigated the influence of comorbidity, PS and age on nab-paclitaxel and gemcitabine (NabGem) effectiveness prof...

Descripción completa

Detalles Bibliográficos
Autores principales: Catalano, Martina, Aprile, Giuseppe, Conca, Raffaele, Petrioli, Roberto, Ramello, Monica, Roviello, Giandomenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114343/
https://www.ncbi.nlm.nih.gov/pubmed/35581246
http://dx.doi.org/10.1038/s41598-022-12214-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114343/
https://www.ncbi.nlm.nih.gov/pubmed/35581246
http://dx.doi.org/10.1038/s41598-022-12214-4

Ejemplares similares